Regulatory preclinical studies for COVID-19 drug development

Souris

Service description

All regulatory tests necessary for COVID-19 preclinical drug development dossier: toxicity, carcinogenicity, in vitro and in vivo in small animals.

This service is designed for Biotech companies developing SARS-CoV-2 new drugs.

Materials to provide

  • Details about the request
  • A specific regulatory process may be required for projects approval

    Further details on the project may be requested.

You will be able to exchange directly with the experts after filling in the form below.

Typical deliverables

  • Study following the specifications validated with the Expert

Get started with your COVID-19 preclinical in vivo and in vitro tests

Please answer the fields below to be contacted by our team of scientists

section1-3
Back
home